EN | RU
EN | RU

Help Support

Back

Efficacy of ultrasound-guided low-molecular-weight hyaluronic acid injections in RA patients

Efficacy of ultrasound-guided low-molecular-weight hyaluronic acid injections in RA patients Efficacy of ultrasound-guided low-molecular-weight hyaluronic acid injections in RA patients
Efficacy of ultrasound-guided low-molecular-weight hyaluronic acid injections in RA patients Efficacy of ultrasound-guided low-molecular-weight hyaluronic acid injections in RA patients

What's new?

HA injection can be considered a safe and effective, adjunctive treatment for short-term pain releif and functional improvement for ankles and feet of RA patients.

Rheumatoid arthritis (RA) cause pain and inflammation in the affecting joints. The study mentioned here was performed to reveal whether hyaluronic acid (HA) injection into rheumatoid arthritis ankles and feet can achieve improvement in foot function and lessen synovial hyper-vascularization.

A total of 44 patients suffering from RA having unilateral or bilateral painful ankle and foot involvement (N = 75) were studied. All the patients were randomized to obtain HA (N = 40) or lidocaine (LI) (N = 35) injection at 2-week intervals. At baseline, 4 weeks (first evaluation) and 12 weeks (secondary evaluation), the clinical estimation was performed via a visual analog scale (VAS) and foot function index (FFItotal) including subscales of pain (FFIpain) before injection. The color Doppler ultrasound (CDUS) and synovitis scores were used for the imaging evaluation performed concurrently. At the first evaluation, HA injection improved the VAS score (p = .009), FFIpain (p = .041), and FFItotal(p = .032) considerably more than LI injections. At the first evaluation (p = .005) and secondary evaluation (p < .001), the CDUS values decreased notably compared with the base line values. The CDUS values of more than half of the joints (54%, p = .042) were reduced due to HA injections while  the control group displayed no change (20%, p = .56). Although, HA injection did not decrease the CDUS values more than LI injection did. No noteworthy difference was observed between or within the groups in the synovitis scores concerning the evaluation of synovial hypertrophy.

Improvement was observed in foot function and pain reduction due to HA injection. HA injection may have a modest consequence in reducing synovial hyper-vascularization. Further large-scale study are needed to confirm this outcome.

Source:

Modern rheumatology

Article:

Short-term effect of ultrasound-guided low-molecular-weight hyaluronic acid injection on clinical outcomes and imaging changes in patients with rheumatoid arthritis of the ankle and foot joints. A randomized controlled pilot trial

Authors:

Chien-Chih Wang et al.

Comments (2)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: